PTC Therapeutics Inc Q2 2023 Earnings Call Transcript - Thomson StreetEvents

PTC Therapeutics Inc Q2 2023 Earnings Call Transcript

PTC Therapeutics Inc Q2 2023 Earnings Call Transcript - Thomson StreetEvents
PTC Therapeutics Inc Q2 2023 Earnings Call Transcript
Published Aug 03, 2023
19 pages (12847 words) — Published Aug 03, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of PTCT.OQ earnings conference call or presentation 3-Aug-23 8:30pm GMT

  
Brief Excerpt:

...Operator Good day and thank you for standing by, and welcome to the PTC Second Quarter 2023 Financial Results Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Senior Director of Investor Relations, Ron Aldridge. You may begin. Ron Aldridge Good afternoon, and thank you for joining us today to discuss the PTC Therapeutics second quarter 2023 corporate update and financial results. I am joined today by our Chief Executive Officer, Dr. Matthew Klein; our Chief Business Officer, Eric Pauwels; our Chief Commercial Officer, Kylie O'Keefe; and our Chief Financial Officer, Pierre Gravier. Today's call will include forward-looking statements based upon our current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as such statements are...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
PTC Therapeutics Inc
Ticker
PTCT.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kristen Brianne Kluska - Cantor Fitzgerald & Co., Research Division - Analyst : Welcome, Pierre. First, just wanted to ask what the main questions will be at PKU pre-NDA meeting and essentially what feedback you're looking for here.

Question: Kristen Brianne Kluska - Cantor Fitzgerald & Co., Research Division - Analyst : Okay. And we've often talked to you about the synergies with the splicing platform, especially now that you're progressing along with Huntington's disease. But maybe just kind of wanted to ask a question from the sense of how much overlap you think there is with the neurologist community, in particular, the adult community with the experience with Evrysdi, given the launch has been pretty substantial here. And then if you have any initial feedback that you've heard from some leaders in the space based off your early data.

Table Of Contents

PTC Therapeutics Inc To Host PIVOT-HD 12-Month Interim Results Transcript – 2024-06-20 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 20-Jun-24 12:00pm GMT

PTC Therapeutics Inc Annual Shareholders Meeting Transcript – 2024-06-18 – US$ 54.00 – Edited Transcript of PTCT.OQ shareholder or annual meeting 18-Jun-24 1:00pm GMT

PTC Therapeutics Inc Q3 2023 Earnings Call Transcript – 2023-10-26 – US$ 54.00 – Edited Transcript of PTCT.OQ earnings conference call or presentation 26-Oct-23 8:30pm GMT

PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript – 2023-09-15 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 15-Sep-23 12:45pm GMT

PTC Therapeutics Inc at Citi BioPharma Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of PTCT.OQ presentation 6-Sep-23 1:40pm GMT

PTC Therapeutics Inc Phenylketonuria (PKU) and Sepiapterin - Corporate Call Transcript – 2023-07-19 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 19-Jul-23 4:00pm GMT

PTC Therapeutics Inc PIVOT-HD Interim Data Update Call Transcript – 2023-06-21 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 21-Jun-23 12:00pm GMT

PTC Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of PTCT.OQ presentation 14-Jun-23 5:40pm GMT

PTC Therapeutics Inc at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of PTCT.OQ presentation 7-Jun-23 4:30pm GMT

PTC Therapeutics Inc MOVE-FA Topline Results-Call Transcript – 2023-05-23 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 23-May-23 9:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "PTC Therapeutics Inc Q2 2023 Earnings Call Transcript" Aug 03, 2023. Alacra Store. May 24, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-PTC-Therapeutics-Inc-Earnings-Call-T15665974>
  
APA:
Thomson StreetEvents. (2023). PTC Therapeutics Inc Q2 2023 Earnings Call Transcript Aug 03, 2023. New York, NY: Alacra Store. Retrieved May 24, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-PTC-Therapeutics-Inc-Earnings-Call-T15665974>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.